The influence of varus insertion of femoral implants in uncemented total hip replacement arthroplasty (THR) remains unclear. Thus, in this study, we retrospectively assessed the clinical impact of uncemented THR with femoral implants that were inserted in varus on the basis of radiological findings.
Introduction
The long-term clinical outcomes of varus insertion of femoral implants in cemented total hip replacement arthroplasty (THR) are poor because of the prevalence of postoperative complications, such as breakage of cement in Gruen's zone 7 due to the concentration of force 1,2 .
However, a few studies have reported that varus insertion in uncemented THR does not influence short-to mid-term clinical outcomes 3, 4 . Therefore, we retrospectively investigated the impact of varus insertion of femoral implants, particularly on bone atrophy due to stress shielding, on the basis of clinical outcomes and radiological findings.
Materials and Methods
The study cohort included a total of 89 patients (9 males and 80 females) who underwent THR for 106 joints at our hospital and were followed-up for >3 years. The mean patient age at the time of surgery was 64.6 years, and the mean follow-up period was 6.9 years. All the surgeries were performed via the posterolateral approach with the patients in the lateral position using the VerSys Fig. 1 Engh's classification system of stress shielding Typical X-ray photos of each degree of stress shielding are shown. Fig. 1 ). The third and fourth degree in which bone resorption extended below the lesser trochanter was defined as severe stress shielding. The severity of stress shielding was categorized as the first, second, or ! third degree.
Statistical analysis was conducted using SPSS 21 (SPSS Inc, Chicago, IL, USA). The paired t-test was used for comparisons of clinical outcomes between the two groups, and the χ 2 test was used to compare appearance rates. P value less than 0.05 was considered statistically significant.
Results
Of the 106 joints assessed in this study, 40 exhibited varus insertion of femoral implants (the varus group) and the other 66 joints did not (the non-varus group).
There were no statistical differences between the patient profiles of the varus and non-varus group (4 males/36 females; mean age, 70.5 years vs. 5 males/61 females; mean age, 70.8 years, respectively). The JOA pain score and flexion/abduction ROM significantly improved in both the varus and non-varus groups at the final followup (38.5 and 38.3 points, respectively) as compared with that before the surgery (15.9 and 16.6 points, respectively); however, these differences were not significant (Fig. 2) . The mean flexion angles improved from 63.8°a nd 57.8°before surgery in the varus and non-varus groups, respectively, to 90.9°and 86.0°, respectively, at Fig. 2 JOA pain score JOA pain score significantly improved in both groups. There were no significant differences between the two groups.
Fig. 3 ROM of flexion angle
The mean flexion angle significantly improved in both groups at the final follow-up. There were no significant differences between the two groups.
the final follow-up (Fig. 3) . The mean abduction angle improved from 14.7°and 10.3°before the surgery in the varus and non-varus groups, respectively, to 23.8°and 22.3°, respectively, at the final follow-up (Fig. 4) . There were no significant differences in ROM measurements between the two groups. The rate of severe stress shielding of ! third degree in the varus group was significantly greater than that in the non-varus group (Table 2, Fig. 5 ).
Discussion

Varus insertion of a femoral implant in uncemented THR
is considered to occur because the femoral implants tend The mean abduction angle significantly improved in both groups at the final followup. There were no significant differences between the two groups. Fig. 5 Appearance rate of stress shielding The appearance rate of stress shielding of ≥3rd degree in the varus group was significantly greater than that in the non-varus group. however, because these data were obtained over shortterm observational periods, long-term results remain unknown. In this study cohort, varus insertion of the femoral implants led to severe stress shielding. Thus, the fra-gility of the atrophied femur may have an important impact on the incidence of periprosthetic fracture or difficulty of re-operation in case of revision surgery.
Reportedly, the causes of stress shielding in uncemented THR were as follows: the size of the implant, characteristics of the implant material, property of the implant surface 6 , and surgical procedure 7 . In this study, change in the transmission of the load to the femur may have occurred in cases of varus insertion of the femoral implant; thus, the surgical technique appears to be one of the most important considerations to prevent this phenomenon.
To overcome stress shielding in uncemented THR, the use of a different femoral implant material has been suggested in a study of femoral implants composed of a material that closely resembles the stiffness of natural bone 8 .
As a more realistic approach, administration of bisphosphonate, which is used to inhibit bone resorption in os- However, Muren et al 11 recently reported that administration of risedronate had no effect on periprosthetic bone atrophy. Although the effect of bisphosphonate remains controversial, if varus insertion is observed on postoperative X-rays, the administration of these drugs should be considered. Nonetheless, it is certain that avoiding varus insertion of femoral implants in the first place is the most important preventative measure.
Conclusions
The results of this study revealed that varus insertion of femoral implants had no influence on short-to mid-term clinical outcomes. However, high rates of severe stress shielding appeared with varus insertion of femoral implants, suggesting possible influences on long-term clinical outcomes.
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